Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

22.6K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.5K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Experimental RNAi02:15

Experimental RNAi

6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Oleanolic acid 28-O-β-D-glucopyranoside alleviates TNBS-induced ulcerative colitis in rat by regulating Nrf2/x-CT/GPX4-mediated ferroptosis" [Journal of Ethnopharmacology 353 (2025) 120369].

Journal of ethnopharmacology·2026
Same author

Targeting barrier integrity: Pseudoginsenoside RT2 ameliorates ulcerative colitis by driving epithelial renewal via the Wnt/β-catenin pathway.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Elevating RNA m<sup>5</sup>C methylation provides a promising strategy for crop productivity.

National science review·2026
Same author

Research landscape, knowledge structure, and emerging frontiers of robot-assisted surgery for urolithiasis: a bibliometric and visualization analysis.

Journal of robotic surgery·2026
Same author

Laparoendoscopic single-site versus conventional laparoscopic living donor nephrectomy: a systematic review and meta-analysis of randomized controlled trials.

International urology and nephrology·2026
Same author

Multi-omics integration maps CHH methylation and gene regulatory networks across heat, drought, and salt stress in rice.

Cell reports·2026

Related Experiment Video

Updated: Jun 26, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.4K

Exosome-transmitted circular RNA circ-LMO7 facilitates the progression of osteosarcoma by regulating

Anyu Luo1, Hanlin Liu1, Chen Huang1

  • 1Department of Orthopedics, Hanyang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.

Cancer Biology & Therapy
|May 14, 2024
PubMed
Summary
This summary is machine-generated.

Circular RNA LMO7 (circLMO7) acts as a tumor suppressor in Osteosarcoma (OS) by inhibiting cell growth and metastasis. This study elucidates the circLMO7/miR-21-5p/ARHGAP24 pathway, revealing its role in OS progression.

Keywords:
ARHGAP24Osteosarcomacirc-LMO7exosomemiR-21-5p

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.2K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K

Related Experiment Videos

Last Updated: Jun 26, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.4K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.2K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer, but their specific functions in Osteosarcoma (OS) remain largely unexplored.
  • Understanding the regulatory mechanisms of circRNAs in OS malignant behaviors is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role and underlying mechanism of circLMO7 in regulating the proliferation, migration, and invasion of Osteosarcoma cells.
  • To identify the key molecular players involved in the circLMO7-mediated regulation of OS progression.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) to detect expression levels of circLMO7, miR-21-5p, and ARHGAP24.
  • Bioinformatics analysis and luciferase reporter gene assays to confirm interactions between circLMO7, miR-21-5p, and ARHGAP24.
  • Cell proliferation, invasion, migration, and apoptosis assays (CCK-8, Transwell, flow cytometry) and Western blotting to assess cellular behaviors and protein levels.

Main Results:

  • CircLMO7 expression was significantly downregulated in OS tissues and cell lines.
  • Overexpression of circLMO7 inhibited OS cell growth, invasion, and migration, while its downregulation promoted these malignant phenotypes.
  • CircLMO7 functions as a sponge for miR-21-5p, and ARHGAP24 is a direct target of miR-21-5p. The circLMO7/miR-21-5p/ARHGAP24 axis was identified as a key regulator of OS progression, with exosomal circLMO7 suppressing OS cell proliferation.

Conclusions:

  • CircLMO7 acts as a tumor suppressor in Osteosarcoma.
  • The identified circLMO7/miR-21-5p/ARHGAP24 axis plays a critical role in OS progression.
  • Exosomal circLMO7 holds potential as a therapeutic agent for Osteosarcoma.